Successful treatment of fulminant pneumococcal sepsis with recombinant tissue plasminogen activator

Author： Akol H.   Boon E.S.   van Haren F.M.P.   van der Hoeven J.G.  

Publisher： Elsevier

ISSN： 0953-6205

Source： European Journal of Internal Medicine, Vol.13, Iss.6, 2002-09, pp. : 389-391

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Repeated Intravenous Treatment with Recombinant Tissue-Type Plasminogen Activator in Patients with Acute Ischemic Stroke

By  

European Neurology, Vol. 74, Iss. 3-4, 2015-09 ,pp. : 127-134

Karger

Access to resources Recommend Favorite

Does Clinical-CT ‘Mismatch’ Predict Early Response to Treatment with Recombinant Tissue Plasminogen Activator?

By  

Cerebrovascular Diseases, Vol. 22, Iss. 5-6, 2006-11 ,pp. : 384-388

Karger

Access to resources Recommend Favorite

Fatal Intracerebral Hemorrhage Associated with Administration of Recombinant Tissue Plasminogen Activator in a Stroke Patient on Treatment with Dabigatran

By  

Cerebrovascular Diseases, Vol. 32, Iss. 6, 2011-12 ,pp. : 614-615

Karger

Access to resources Recommend Favorite

AMYLOID PEPTIDES STIMULATE TISSUE-TYPE PLASMINOGEN ACTIVATOR BUT NOT RECOMBINANT PROUROKINASE

By Wnendt S.   Wetzels I.   Gunzler W.A.  

Thrombosis Research, Vol. 85, Iss. 3, 1997-02 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of pulse-sprayed recombinant tissue plasminogen activator for deep venous thrombosis

By Horne M.K.   Chang R.  

Thrombosis Research, Vol. 111, Iss. 1, 2003-01 ,pp. : 111-114

Elsevier

Access to resources Recommend Favorite